Associations of Serum Levels of Advanced Glycation end Products with Nutrition Markers and Anemia in Patients with Chronic Kidney Disease

REFERENCES

• Siems W, Quast S, Carluccio F, Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol. 2002;58(Suppl. 1):S12–S19.
   Web of Science ®Google Scholar
• Stenvinkel P, Heimbürger O, Paultre F, Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–1911.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Advanced glycosylation in diabetes and aging. Annu Rev Med. 1995;46:223–234.
   PubMed Web of Science ®Google Scholar
• Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon- (carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem. 1996;271: 9982–9986.
   PubMed Web of Science ®Google Scholar
• Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582–592.
   PubMed Web of Science ®Google Scholar
• Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol. 2005;289:F645–F659.
   PubMed Web of Science ®Google Scholar
• Daroux M, Prévost G, Maillard-Lefebvre H, Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies. Diabetes Metab. 2010;36:1–10.
   PubMed Web of Science ®Google Scholar
• Hartog JW, Smit AJ, van Son WJ, Advanced glycation end products in kidney transplant patients: A putative role in the development of chronic renal transplant dysfunction. Am J Kidney Dis. 2004;43:966–975.
   PubMedGoogle Scholar
• Berrou J, Tostivint I, Verrecchia F, Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. Int J Mol Med. 2009;23:513–520.
   PubMed Web of Science ®Google Scholar
• Halliwell B. The role of oxygen radicals in human disease with particular reference to vascular system. Hemostasis. 1993;23 (Suppl. 1):118–126.
   PubMedGoogle Scholar
• Boosalis MG, Snowdon DA, Tully CL, Gross MD. Acute phase response and plasma carotenoid concentrations in older women: Findings from the nun study. Nutrition. 1996 Jul–Aug; 12(7–8):475–478.
   Google Scholar
• Henle T, Deppisch R, Beck W, Hergesell O, Hänsch GM, Ritz E. Advanced glycated end-products (AGE) during hemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant. 1999;14:1968–1975.
   PubMed Web of Science ®Google Scholar
• Münch G, Keis R, Wessels A, Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem. 1997;35:669–677.
   PubMedGoogle Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
   PubMed Web of Science ®Google Scholar
• Riella MC. Malnutrition in dialysis: Malnourishment or uremic inflammatory response? Kidney Int. 2000;57:1211–1232.
   PubMedGoogle Scholar
• Caravaca F, Arrobas M, Pizarro JL, Sanchez-Casado E. Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients. Nephrol Dial Transplant. 2001;16:776–782.
   Google Scholar
• Jansen MA, Korevaar JC, Dekker FW, Renal function and nutritional status at the start of chronic dialysis treatment. J Am Soc Nephrol. 2001;12:157–163.
   Google Scholar
• Wautier JL, Schmidt AM. Protein glycation: A firm link to endothelial cell dysfunction. Circ Res. 2004;95:233–238.
   PubMed Web of Science ®Google Scholar
• Horie K, Miyata T, Maeda K, Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest. 1997;100:2995–3004.
   PubMed Web of Science ®Google Scholar
• Yamada K, Miyahara Y, Hamaguchi K, Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol. 1994;42:354–361.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A. 1994;91:11704–11708.
   PubMed Web of Science ®Google Scholar
• Gugliucci A, Bendayan M. Reaction of advanced glycation endproducts with renal tissue from normal and streptozotocin-induced diabetic rats: An ultrastructural study using colloidal gold cytochemistry. J Histochem Cytochem. 1995;43: 591–600.
   PubMed Web of Science ®Google Scholar
• Semba RD, Ferrucci L, Fink JC, Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women. Am J Kidney Dis. 2009;53:51–58.
   PubMed Web of Science ®Google Scholar
• Kilhovd BK, Juutilainen A, Lehto S, High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: A population-based 18-year follow-up study. Arterioscler Thromb Vasc Biol. 2005;25:815–820.
   PubMed Web of Science ®Google Scholar
• Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int. 1994;46:216–222.
   PubMedGoogle Scholar
• Makita Z, Bucala R, Rayfield EJ, Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet. 1994;343:1519–1522.
   PubMed Web of Science ®Google Scholar
• Vlassara H. Serum advanced glycosylation end products: A new class of uremic toxins? Blood Purif. 1994;12:54–59.
   Google Scholar
• Kalousová M, Zima T, Tesař V, Glycoxidation in hemodialyzed patients with diabetes mellitus. In: Timio M, Wiyemann V, Venanzi, eds. Cardionephrology. Vol. 7. Cosenza, Italy: Editoriale Bios; 2002:297–300.
   Google Scholar
• Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia? Kidney Int. 1998;54: 1290–1295.
   PubMed Web of Science ®Google Scholar
• Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int. 1999;55:389–399.
   PubMed Web of Science ®Google Scholar
• Schwedler SB, Metzger T, Schinzel R, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int. 2002;62:301–310.
   PubMed Web of Science ®Google Scholar
• Wagner Z, Molnár M, Molnár GA, Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:294–300.
   PubMed Web of Science ®Google Scholar
• Teplan V, Vyhnálek F, Gürlich R, Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien Klin Wochenschr. 2010; 122(15–16):466–473.
   Google Scholar
• Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953–960.
   PubMed Web of Science ®Google Scholar
• Romão JE Jr, Haiashi AR, Elias RM, Positive acute-phase inflammatory markers in different stages of chronic kidney disease. Am J Nephrol. 2006;26:59–66.
   Google Scholar
• Kalousová M, Sulková S, Fialová L, Glycoxidation and inflammation in chronic hemodialysis patients. Nephrol Dial Transplant. 2003;18:2577–2581.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Tsalamandris C, MacIsaac R, Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int. 2004;66:1167–1172.
   PubMed Web of Science ®Google Scholar
• Holland DC, Lam M. Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study. Nephrol Dial Transplant. 2000;15:650–658.
   PubMed Web of Science ®Google Scholar
• McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol. 2002;13:1928–1936.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Thorpe SR, Thallas-Bonke V, Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol. 2005;16:2363–2372.
   PubMed Web of Science ®Google Scholar